Repligen (RGEN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $176.89 -0.73%
Revenue Growth %: +9.4%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.4%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $29.2 million versus the consensus estimate of $24.75 million.
GUIDANCE:
Repligen sees FY2016 EPS of $0.42-$0.48, versus the consensus of $0.47. Repligen sees FY2016 revenue of $101-105 million, versus the consensus of $99.5 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
